YL

Yi Liu

IN Intel: 7 patents #234 of 5,207Top 5%
IP Infinity Pharmaceuticals: 2 patents #10 of 37Top 30%
AP Araxes Pharma: 1 patents #1 of 5Top 20%
Johnson & Johnson: 1 patents #405 of 988Top 45%
Overall (2016): #4,914 of 481,213Top 2%
11
Patents 2016

Issued Patents 2016

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
9522146 Substituted Isoquinolin-1(2H)-one compounds, compositions, and methods thereof Pingda Ren, Troy Edward Wilson, Liansheng Li, Katrina Chan, Christian Rommel 2016-12-20
9434711 Sulfonamides as TRPM8 modulators Shawn Branum, Raymond W. Colburn, Scott L. Dax, Christopher Flores, Michele C. Jetter +11 more 2016-09-06
9388183 Heterocyclic compounds and uses thereof Pingda Ren, Liansheng Li, Katrina Chan, Troy Edward Wilson, Alfredo C. Castro +2 more 2016-07-12
9359349 Substituted quinazolines as kinase inhibitors Pingda Ren, Troy Edward Wilson 2016-06-07
9359352 Substituted benzimidazoles as PI3 kinase inhibitors Pingda Ren, Liansheng Li, Katrina Chan, Troy Edward Wilson, Simon F. Campbell 2016-06-07
9345706 Benzoxazole kinase inhibitors and methods of use Pingda Ren, Troy Edward Wilson, Liansheng Li, Katrina Chan 2016-05-24
9315505 Heterocyclic compounds and uses thereof Pingda Ren, Liansheng Li, Troy Edward Wilson 2016-04-19
9296742 Heterocyclic kinase inhibitors Pingda Ren, Liansheng Li, Katrina Chan, Troy Edward Wilson 2016-03-29
9295673 Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof Pingda Ren, Katayoun Jessen, Xin Guo, Christian Rommel, Troy Edward Wilson 2016-03-29
9255108 Heterocyclic compounds and uses thereof Alfredo C. Castro, Katrina Chan, Catherine A. Evans, Somarajannair Janardanannair, Andre Lescarbeau +5 more 2016-02-09
9227978 Covalent inhibitors of Kras G12C Pingda Ren, Liansheng Li, Jun Feng, Tao Wu 2016-01-05